Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study

Por Wvan der Zanden, Rogier, de Vries, Frank, Lalmohamed, Arief, Driessen, Johanna H. M., de Boer, Anthonius, Rohde, Gernot, Neef, Cees, den Heijer, Casper
Publicado no PLoS One (2015)

The use of incretins and fractures – a meta‐analysis on population‐based real life data

Por Driessen, Johanna H. M., de Vries, Frank, van Onzenoort, Hein, Harvey, Nicholas C., Neef, Cees, van den Bergh, Joop P. W., Vestergaard, Peter, Henry, Ronald M. A.
Publicado no Br J Clin Pharmacol (2016)

Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study

Por van Dalem, Judith, Brouwers, Martijn C G J, Stehouwer, Coen D A, Krings, André, Leufkens, Hubert G M, Driessen, Johanna H M, de Vries, Frank, Burden, Andrea M
Publicado no BMJ (2016)

Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs

Por Driessen, Johanna H. M., van Onzenoort, Hein A. W., Starup-Linde, Jakob, Henry, Ronald, Burden, Andrea M., Neef, Cees, van den Bergh, Joop P., Vestergaard, Peter, de Vries, Frank
Publicado no Calcif Tissue Int (2015)

Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis

Por Driessen, Johanna H. M., Henry, Ronald M. A., van Onzenoort, Hein A. W., Lalmohamed, Arief, Burden, Andrea M., Prieto-Alhambra, Daniel, Neef, Cees, Leufkens, Hubert G. M., de Vries, Frank
Publicado no Calcif Tissue Int (2015)